Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Physical Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06002620
What this trial is testing

Healthynsect Child Growth and Health Intervention Study

Who this might be right for
Nutrition Status
University of Copenhagen 284
Not applicableStudy completedNCT04630223
What this trial is testing

Levels of Endocan in Umbilical Cord Blood Samples of Pregnant Females With Intrauterine Growth Retardation

Who this might be right for
Intrauterine Retardation
Van Bölge Eğitim ve Araştırma Hastanesi 100
Not applicableStudy completedNCT00476879
What this trial is testing

Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content

Who this might be right for
MetabolismFatty Liver
University of Aarhus 10
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04765059
What this trial is testing

Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 98
Not applicableUnknownNCT05328674
What this trial is testing

Clinical and Comparative Evaluation of the Treatment Results of Arthroscopic Reconstruction of Cartilage Defects in the Knee Joint With the Use of Autogenous Cartilage Graft With PRP GF (Platelet-rich Plasma With Growth Factors)

Who this might be right for
Cartilage DamageCartilage InjuryKnee Injuries
eMKa MED Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT05599282
What this trial is testing

The Efficacy and Safety of an Amino Acid Supplement in Adults

Who this might be right for
Insulin-Like Growth Factor IHealthy
ZandA Technologies, llc 120
Post-approval studies (Phase 4)Study completedNCT02125864
What this trial is testing

Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept

Who this might be right for
Exudative Age-related Macular Degeneration
Oslo University Hospital 16
Testing effectiveness (Phase 2)Ended earlyNCT00074334
What this trial is testing

TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 3
Not applicableStudy completedNCT00667134
What this trial is testing

Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
University of Michigan 26
Very early researchStudy completedNCT04554732
What this trial is testing

Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia

Who this might be right for
AlopeciaChemotherapy-Induced ChangeHair Loss+1 more
University of Arizona 28
Not applicableStudy completedNCT03455387
What this trial is testing

Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.

Who this might be right for
Pre-EclampsiaHELLP SyndromeFetal Death+3 more
Centre Hospitalier Metropole Savoie 233
Early research (Phase 1)Study completedNCT04572295
What this trial is testing

E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Eisai Co., Ltd. 51
Testing effectiveness (Phase 2)Ended earlyNCT00861471
What this trial is testing

Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer

Who this might be right for
Prostate CancerProstatic Neoplasms
NYU Langone Health 24
Not applicableStudy completedNCT03808571
What this trial is testing

Cord Blood Nesfatin-1 and Irisin in the Intrauterine Growth Restricted Fetuses

Who this might be right for
Nesfatin-1IrisinIntrauterine Growth Restriction
Yuzuncu Yil University 66
Not applicableActive Not RecruitingNCT07111299
What this trial is testing

Clinical Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human Volunteers Versus Placebo

Who this might be right for
Early Female Pattern Hair Loss (FPHL)
Olistic Research Labs S.L. 100
Not applicableLooking for participantsNCT06208397
What this trial is testing

MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases

Who this might be right for
Metastatic Colorectal Cancer
Shengjing Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07157969
What this trial is testing

ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
Peking Union Medical College Hospital 300
Large-scale testing (Phase 3)UnknownNCT06007417
What this trial is testing

Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency

Who this might be right for
GHD
Changchun GeneScience Pharmaceutical Co., Ltd. 162
Large-scale testing (Phase 3)Looking for participantsNCT07185997
What this trial is testing

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Who this might be right for
Non-Small-Cell Lung CancerMetastatic Non-Small-Cell Lung CancerAdvanced Non-Small-Cell Lung Cancer+3 more
ArriVent BioPharma, Inc.
Next Page
480